Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia.
about
Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II studyDecitabine for acute myeloid leukemia.Targeting DNA methylation for epigenetic therapy.Acute myeloid leukemia: focus on novel therapeutic strategies.Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia.Clinical outcome of treatment with a combined regimen of decitabine and aclacinomycin/cytarabine for patients with refractory acute myeloid leukemia.5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy.
P2860
Q33558088-9CA9EAB2-F5B3-4BED-9115-47CD53E258C3Q34257184-D344A843-7F54-4EBD-BB2E-92E7713BE884Q34258037-6CFD441B-B593-421C-A737-CF9E96AF454EQ38015336-0568535E-561A-4BD7-8866-0B8B993A19DCQ45340990-EC48DCE1-6925-4EEA-AE0A-EA3D3ED35F00Q47259985-9662FF04-E6C5-4548-AB59-0204BFEB66CDQ51039721-FE5D07F3-5B39-428B-B86F-851740821DCD
P2860
Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Decitabine combined with fract ...... actory acute myeloid leukemia.
@en
Decitabine combined with fract ...... actory acute myeloid leukemia.
@nl
type
label
Decitabine combined with fract ...... actory acute myeloid leukemia.
@en
Decitabine combined with fract ...... actory acute myeloid leukemia.
@nl
prefLabel
Decitabine combined with fract ...... actory acute myeloid leukemia.
@en
Decitabine combined with fract ...... actory acute myeloid leukemia.
@nl
P2093
P356
P1476
Decitabine combined with fract ...... actory acute myeloid leukemia.
@en
P2093
Peter W Marks
Saeeda Chowdhury
Stuart Seropian
P304
P356
10.1002/AJH.21478
P577
2009-09-01T00:00:00Z